Curious to see your top suppliers emissions?
Book a demo for a pilot project
Book a demo for a pilot project
Phc Holdings Corporation, commonly referred to as PHC Holdings, is a leading player in the healthcare and life sciences industry, headquartered in Japan. Founded in 1948, the company has established a strong presence in major operational regions, including Asia, Europe, and North America. PHC Holdings is renowned for its innovative medical devices, diagnostic solutions, and healthcare IT services, which are designed to enhance patient care and streamline clinical workflows.
With a commitment to quality and technological advancement, PHC Holdings has achieved significant milestones, including the development of cutting-edge products that cater to diverse healthcare needs. The company’s unique offerings, such as advanced blood glucose monitoring systems and laboratory automation solutions, position it as a trusted partner in the global healthcare landscape. Recognised for its excellence, PHC Holdings continues to drive progress in the industry, making a meaningful impact on health outcomes worldwide.
+10 vs industry average
Phc Holdings’s score of 38 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Surgical and Medical Instrument Manufacturing has above-average carbon intensity
The Surgical and Medical Instrument Manufacturing industry has reduced its overall emissions by 32% since 2018
Scope 3 accounts for ••• of total emissions.
In 2023, PHC Holdings Corporation reported total greenhouse gas emissions of approximately 813,000,000 kg CO2e. This total includes 15,861,000 kg CO2e from Scope 1 emissions, 35,304,000 kg CO2e from Scope 2 emissions, and a significant 793,687,000 kg CO2e from Scope 3 emissions.
PHC Holdings has set ambitious climate commitments, aiming for carbon neutrality by 2040. The company has established specific reduction targets, including a 42% reduction in absolute Scope 1 and Scope 2 emissions by 2030, using 2023 as the baseline year. Additionally, they aim for a 25% reduction in Scope 3 emissions within the same timeframe. These targets align with the Science Based Targets initiative (SBTi) and are designed to contribute to limiting global warming to 1.5°C.
The company's climate strategy reflects a comprehensive approach to sustainability, focusing on energy efficiency and resource conservation across its operations. As a leader in the healthcare equipment and supplies sector, PHC Holdings is committed to reducing its environmental impact while maintaining operational excellence.
Access structured emission data, company specific factors and auditable source documents
2030
42% reduction in Scope 2
PHC Holdings Corporation commits to reduce absolute scope 2 GHG emissions 42% by FY2030 from a FY2023 base year.
2030
42% reduction in Scope 1
PHC Holdings Corporation commits to reduce absolute scope 1 GHG emissions 42% by FY2030 from a FY2023 base year.
2030
25% reduction in scope 3 total
PHC Holdings Corporation also commits to reduce absolute scope 3 GHG emissions from purchased goods and services, upstream transportation an…
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
No scope 3 category breakdown has been disclosed yet.


Common questions about Phc Holdings’s sustainability data and climate commitments
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more